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Antagonistic roles of Notch and p63 in controlling
mammary epithelial cell fates
O¨ Yalcin-Ozuysal1,4, M Fiche2, M Guitierrez1, K-U Wagner3, W Raffoul2 and C Brisken*,1
The breast epithelium has two major compartments, luminal and basal cells, that are established and maintained by poorly
understood mechanisms. The p53 homolog, p63, is required for the formation of mammary buds, but its function in the breast
after birth is unknown. We show that in primary human breast epithelial cells, maintenance of basal cell characteristics depends
on continued expression of the p63 isoform, DNp63, which is expressed in the basal compartment. Forced expression of DNp63
in purified luminal cells confers a basal phenotype. Notch signaling downmodulates DNp63 expression and mimics DNp63
depletion, whereas forced expression of DNp63 partially counteracts the effects of Notch. Consistent with Notch activation
specifying luminal cell fate in the mammary gland, Notch signaling activity is specifically detected in mice at sites of pubertal
ductal morphogenesis where luminal cell fate is determined. Basal cells in which Notch signaling is active show decreased p63
expression. Both constitutive expression of DNp63 and ablation of Notch signaling are incompatible with luminal cell fate. Thus,
the balance between basal and luminal cell compartments of the breast is regulated by antagonistic functions of DNp63 and
Notch.
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The breast epithelium consists of two cell compartments,
luminal and basal. Luminal cells are connected by tight
junctions and form a single layer of polarized epithelium
around the ductal lumen. They express cytokeratin (CK)
18 and high levels of heat-stable surface antigen CD24.1–2
About a third of the luminal epithelial cells express the nuclear
hormone receptors, estrogen receptor-a (ERa) and proges-
terone receptor,3 and act as sensor cells by detecting steroid
hormones and translating this systemic stimulus into local
autocrine/paracrine signals.4
The basal compartment comprises all the cells that do not
touch the lumen, these include progenitors and myoepithelial
cells.2 The latter are contractile, form a meshwork around the
luminal cells, and have a role in milk ejection during lactation.
Basal cells express CK14 and have extensive contact with the
basal lamina, dependent on high expression of the adhesion
molecules integrin b4 (ITGB4) and a6 (ITGA6).5–6 Human
basal and luminal cells can be separated based on differential
expression of the surface antigen CD10;1 their murine
counterparts can be distinguished by their CD24 immuno
phenotype, with basal cells expressing low (CD24lo) and
luminal cells expressing high levels (CD24hi).2
Fluorescence-activated cell sorting (FACS) experiments
with mouse mammary epithelial cells (MMECs) have shown
that CD24lo populations with high expression of ITGB1
(CD29hi) or ITGA6 (CD49fhi) are enriched for cells with
in vivo reconstitution potential.7–8 It is thought that mammary
stem cells of CD24loCD29hi/CD49fhi phenotype, give rise,
either directly or through intermediary cell stages, to bipotent
progenitors. These in turn generate basal/myoepithelial and
luminal progenitors that differentiate into mature myoepithelial
cells and different types of luminal cells that can be alveolar
or ductal and ERa positive or negative.9
Recently, Notch signaling has been implicated in controlling
stem cells and lineage commitment in different ways.10–12
Binding of ligands, Jagged1 and 2, and Dll1, 3, and
4 expressed on the surface of neighboring cells leads to
cleavage of Notch receptors (1–4) and release of the Notch
intracellular domain, which converts the DNA-binding protein
CBF1/Rbp-Jk from a repressor to an activator of transcrip-
tion.13 On the one hand, Notch activation promoted self-
renewal of stem cells, proliferation of progenitor cells, and
commitment to the myoepithelial lineage in human breast
epithelial cells (HBECs), as assessed by the mammosphere
assay.11 On the other hand, cell separation experiments
combined with colony-forming assays suggested that Notch
signaling restricts bipotential human progenitors to a luminal
cell fate10 and downmodulation of Rbp-Jk in mouse progenitor
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cells increased their reconstitution potential.12 Notch signaling
has long been established as oncogenic in the mammary
epithelium as a mouse mammary tumor virus (MMTV)
insertion resulting in a truncated, constitutively active Notch4
caused mammary tumors at high frequency.14 It has also
been implicated in human breast carcinogenesis, with
expression of its inhibitor Numb being lost in 50% of mammary
carcinomas.15 Increased expression of Jagged-1 has been
associated with a bad prognosis.16 Whether the dual role of
Notch, alternatively oncogenic or differentiation inducing,
depends on cellular context, developmental stage, hormonal
milieu, and/or different receptors with Notch1 and 3 implicated
in differentiation10 and Notch4 controlling stem cells10–11
remains to be addressed. Indeed, little is known about the
downstream mechanisms involved in Notch function in the
breast.
p63, similar to its homologs p53 and p73, is a sequence-
specific DNA-binding protein.17 Expression from different
promoters produces two protein isoforms, TAp63 or
DNp63, which either contain or lack the N-terminal transacti-
vation domain. Each isoform has three different C-terminal
variants due to differential mRNA splicing (a, b, and g).17
Mutations in p63 are implicated in a broad spectrum of human
syndromes with deficiencies in epithelial homeostasis.18
Among them is the limb–mammary syndrome, involving
hypoplasia/aplasia of the mammary gland and nipple, in
which mutations in exons 13 and 14 lead to a frameshift
mutation resulting in a truncated protein.18
Deletion of p63 in the mouse germ line severely impairs skin
development and blocks the formation of mammary glands
and other ectodermal derivatives.19–22 This circumstance
prevented the analysis of p63 function in the mammary gland.
p63 is expressed in the basal compartment of many
epithelia17,20,22 including the breast.23 It has been implicated
in maintaining the proliferation potential of stem cells in the
epidermis21 through the DNp63 isoform, whereas TAp63 is
required in maintaining integrity of the female germ line.24 The
molecular mechanisms underlying p63 function involve
changes in transcription of cell adhesion genes including
different integrins.25
Here, we examine p63 function in primary HBECs from
multiple donors of different genetic backgrounds, and show
Figure 1 Silencing DNp63 expression in CD10(þ )-sorted HBECs induces luminal characteristics. (a) Photomicrographs of CD10(þ )-sorted HBECs 72 h after infection
with control orDNp63 shRNA-expressing lentiviruses. Note lower cell density in DNp63 versus control shRNA-infected cell populations. Scale bar: 0.2 mm. (b) Growth curves
of HBECs from two different patients plated at equal numbers on day 0, at 72 h after infection with control (squares) or DNp63 shRNA-expressing (triangle) lentivirus. (c) Bar
graphs representing percentage of BrdU-positive cells in control (34.1 and 35.7%) and DNp63 shRNA-expressing (4.9 and 7.8%) CD10(þ )-sorted HBECs on day 8 after
infection. (d, e) Expression levels of basal (d) and luminal (e) markers at mRNA and protein levels. Relative mRNA expression levels of basal markers CK14 and ITGA6 (d) and
luminal markers CK18 and CD24 (e) in HBECs from four different individuals after infection with control (filled bars) or DNp63 shRNA (open bars)-expressing virus. mRNA
values represent the mean±S.D. of three replicate samples, normalized to TATA box-binding protein (TBP). (AE: 4, AK: 8, V: 5, W: 3 days after infection) (P-values: CK14,
0.09; ITGA6, 0.12; CK18, 0.12; and CD24, 0.03). Western blot of HBECs day 5 after infection with control shRNA (C) or DNp63 shRNA-expressing lentivirus
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that DNp63 is essential for the maintenance of basal cell fate
and is negatively regulated by Notch signaling. We provide
evidence that this antagonism operates in vivo during pubertal
ductal morphogenesis in the mouse mammary gland.
Results
DNp63 function in maintaining basal versus luminal cell
fates. To assess the role of p63 expression in basal breast
epithelial cells, we performed loss- and gain-of-function
experiments with primary HBECs. We purified luminal and
basal cell populations from reduction mammoplasties using
magnetic beads and an antibody recognizing CD10;1 cell
separation was validated by assessing marker gene expres-
sion (Supplementary Figure 1a). As reported by O’Hare
et al.,26 the two populations had distinct phenotypes:
CD10(þ ) basal HBECs proliferated faster than CD10()
luminal cultures and propagated over eight passages.
CD10(þ ) cells were refractile and tended to scatter (Supple-
mentary Figure 1b). CD10() HBECs formed sheets with
indistinct cell boundaries (Supplementary Figure 1b) and
grew only up to 2–4 passages. Both cultures remained
homogeneous over time and continued to express respective
markers (Supplementary Figure 1c).
Having ascertained that DNp63a is the predominant p63
isoform expressed in HBECs (Supplementary Figure 2a–d),
we downmodulated DNp63 expression in CD10(þ ) cells by
shRNA-mediated knockdown (Supplementary Figure 2c and
d). DNp63 shRNA-expressing cultures grew less dense
(Figure 1a) and increased less in cell numbers (Figure 1b)
than control-infected populations. Consistent with DNp63
downmodulation resulting in decreased proliferation, bromo-
deoxyuridine (BrdU) was incorporated by 34.1 and 35.7% of
the control-infected cells and only by 4.9 and 7.8% of DNp63
shRNA-expressing cells (Figure 1c). Transcript levels of basal
markers such as CK14 and ITGA6 decreased (Figure 1d),
whereas those of the luminal markers, CD24 and CK18,
increased on DNp63 depletion (Figure 1e). Similarly,
ITGA6, ITGB4, and CK14 decreased (Figure 1d) and CK18
(Figure 1e) increased at the protein level. These results
Figure 2 DNp63 expression in CD10()-sorted HBECs induces basal
characteristics. (a) p63 protein levels in CD10() cells on days 3 and 9 after
infection with DNp63-expressing retrovirus compared with endogenous p63 levels
in CD10(þ ) HBECs 3 days after control infection. (b–e) Photomicrographs of
CD10()-sorted HBECs 13 days after infection with control or DNp63-expressing
virus. CD10()-sorted HBECs form islands (b) consisting of flat cells with indistinct
cell borders characteristic of luminal cells (d). DNp63-infected populations show
higher cell density and contain refractile, spindle-shaped cells (c, e). Scale bar:
0.2 mm. (f) Growth curves of HBECs infected with control (squares) or DNp63
(circles)-expressing virus. (g) Percentage of BrdU-positive cells among GFP-
DNp63- (26.7%) and GFP only (16.6%)-expressing cells at day 8 after infection.
(h) Relative mRNA levels of luminal (CK18, CD24) and basal (CK14, ITGA6)
markers in CD10() HBECs from four different donors infected with control (filled
bars) or DNp63 (open bars)-expressing virus (V, 2; S and AK, 7; and W, 10 days
after infection). Values represent the mean±S.D. of three replicate samples
normalized to TBP (P-values: CK14 o0.23; CK18 o0.05; ITGA6 o0.07; and
CD24o0.02). (i) p63, ITGA6, CK14 and CK18 protein levels in CD10()-sorted
HBECs from two different donors at different days after infection with either control
(C) or DNp63 (p63) expressing virus
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suggested that DNp63 expression is required to maintain the
basal versus the luminal phenotype in HBECs.
To address whether DNp63 is sufficient to induce a basal
conversion, we ectopically expressed DNp63 in CD10()
luminal cells. Western blotting revealed that ectopically
expressed p63 in CD10() HBECs reached levels compar-
able with those of endogenous p63 in CD10(þ ) cells 3 days
after infection (Figure 2a). As expected, control-infected
luminal cell populations grew slowly as islands (Figure 2b)
and had indistinct cell borders (Figure 2d). By contrast,
in DNp63-expressing populations, cells became refractile
and scattered similar to basal cells (Figure 2c and e).26 Cell
numbers increased by about fourfold at 9 days and by 40-fold
at 23 days after infection over their respective controls
(Figure 2f). The percentage of cells in S phase increased,
with 26.7% of GFP-DNp63- versus 16.6% of GFP-only-
expressing cells incorporating BrdU (Figure 2g). The morpho-
logical changes were accompanied at the molecular level by
increased CK14 and ITGA6 and decreased CK18 and CD24
mRNA expression (Figure 2h). At the protein level, ITGA6 and
CK14 were increased and CK18 decreased in cultures
expressing DNp63 (Figure 2i). Thus, expression of DNp63 is
sufficient to induce several hallmarks of the basal phenotype
in CD10()-sorted HBECs.
The role of Notch in driving luminal cell fate depends on
negative regulation of DNp63. Our findings suggested that
DNp63 is an essential control element in the maintenance of
basal versus luminal cell fates. Notch3 and Notch1 have
recently been implicated in driving luminal cell fate.10,12 In
keratinocytes, Notch1 signaling promotes differentiation
and negatively regulates p63 expression,27,28 making
Notch signaling an attractive pathway upstream of DNp63
to investigate. To test whether Notch drives luminal cell
commitment by downmodulating DNp63, we expressed the
intracellular domain of Notch1 (NICD) in primary HBECs.
Within 48 h of infection, DNp63 transcript was significantly
decreased (Figure 3a) and DNp63 protein was consistently
reduced (Figure 3b). NICD-expressing HBECs aggregated
and could not be passaged. To assess the effects of Notch
activation on cell proliferation, we expressed NICD under the
control of phosphoglycerate kinase (PGK) promoter. This
approach yielded lower NICD expression levels and less
Notch signaling activation, as assessed by target gene
expression (Supplementary Figure 3a), and allowed us to
passage the NICD-expressing HBECs. Cell density was
reduced by both high and low NICD expression (Figure 3c).
Increase in cell number assessed in low NICD-expressing
HBECs was reduced (Figure 3d). Consistent with this
being due to decreased proliferation, BrdU incorporation
(Figure 3e) and Ki67 labeling (Figure 3f) were lower among
cells expressing NICD and GFP than GFP-only-expressing
cells. Furthermore, increased Notch activity resulted in
significant downmodulation of integrins enriched in basal
cells, such as ITGB1, ITGB4, and ITGA6 (Figure 3g and h),
similar to what was observed in MCF10A cells depleted for
DNp63.25 As we failed to detect increased expression of
the luminal marker CK18 in HBECs with constitutive Notch
activation, we expressed a NICD fused to a mutant ERa
that can be transiently activated by exposure to 4-OH-
tamoxifen.29 Treatment of HBECs expressing this construct
with 4-OH-tamoxifen for 8 h resulted in increased Notch
signaling activity, as assessed by increased mRNA expres-
sion of Hey-1 (Supplementary Figure 3b) and increased
CK18 mRNA expression by 3.4-fold over 14 days (Figure 3i).
Thus, activation of Notch signaling not only downmodulates
DNp63 expression but also has effects on cell proliferation
and marker gene expression similar to those caused by
DNp63 depletion.
To address the functional significance of DNp63 down-
modulation in the context of increased Notch signaling, we
coinfected unsorted HBECs with NICD and DNp63-expres-
sing retroviruses. As expected, in NICD-expressing cultures,
cells aggregated and cell density was reduced compared with
control cultures (Figure 4a and b, left versus middle panels).
In the cultures coexpressing NICD and DNp63, cell density
was comparable with control populations (Figure 4a and b,
right panels). Increased DNp63 expression also counteracted
Notch-induced downmodulation of ITGB1, ITGB4, and ITGA6
at the mRNA level (Figure 4c). At the protein level, Notch-
induced downmodulation of ITGB4 was counteracted by
ectopic DNp63 expression (Figure 4d). Thus, DNp63 down-
modulation is required for, at least, some of the effects of
Notch in HBECs.
DNp63/Notch signaling in vivo. Our findings indicated
that persistent expression of DNp63 is required to maintain
basal cell fate in HBECs by counteracting the role of Notch
in driving and/or maintaining luminal cell fate. Such an
antagonism between Notch signaling and p63 expression
had been suggested to be of importance to maintain luminal
cells, specifically during pregnancy, in the mouse mammary
gland.30 To assess when and where canonical Notch
signaling is active during mammary gland development, we
used a transgenic Notch reporter (TNR) mouse strain, which
includes an EGFP gene downstream of CBF1/RBP-Jk-
responsive element (four CBF1-binding sites and the basal
simian virus 40 promoter). GFP expression was shown to
faithfully reflect CBF1 activity.31 By fluorescent stereo-
microscopy, GFP was first detected in mammary glands
at 3 weeks of age, at the onset of puberty; the signal
peaked between 4 and 6 weeks, it was weak at 12 weeks,
and undetectable thereafter (Figure 5a). Thus, canonical
Notch activity, as detected by this approach, was specific to
pubertal ductal morphogenesis. At this stage of mammary
gland development, extensive cell proliferation occurs at the
tips of the ducts, which enlarge to become terminal end
buds (TEBs).32 TEBs comprise an outer layer of cap cells,
enriched in stem and myoepithelial progenitor cells and
inner body cells considered as luminal precursor cells.32,33
Consistent with an involvement of Notch signaling in cell
fate determination, the GFP signal was strongest at TEBs
and decreased proximally along the subtending ducts
(Figure 5b–d). Coimmunostaining for GFP and p63
revealed that expression of the two was mutually exclusive;
p63 was expressed in cap or myoepithelial cells, whereas
GFP expression was detected in body cells (Figure 5e, left
panel) and luminal cells of the subtending duct (Figure 5e,
right panel).
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According to our model, Notch signaling is initially activated
in basal/progenitor cells, in which it leads to downmodulation
of p63 expression and triggers luminal differentiation. Hence,
a subpopulation of CD24 lo cells was expected to have
active Notch signaling and decreased expression levels of
p63. Low GFP expression and subtle differences in p63
expression might not be discerned by immunohistochemical
approach used in the previous experiment. Hence, we FACS-
sorted MMECs from 4 to 5-week-old reporter mice on the
basis of GFP and CD24 expression after exclusion of stromal
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cells. Both CD24 lo and CD24 hi populations comprised of
GFP-positive cells (Figure 5f). Consistent with the immuno-
fluorescence results, CD24 hi cells expressed higher levels of
GFP both at the protein (Figure 5f) and mRNA levels
(Figure 5g) than CD24 lo cell populations. Furthermore, gene
expression analysis showed that ITGB1 and ITGA6 were
enriched in CD24 lo versus CD24 hi cells and that p63 itself
was expressed at about 170-fold higher levels in CD24 lo than
in CD24 hi MMECs (Figure 5g), validating the cell separation
procedure. Strikingly, among the CD24 lo cells, the GFP-
positive population showed consistently reduced p63 mRNA
expression (Figure 5g). Thus, in CD24 lo MMECs, in which
Notch signaling is or has been active, p63 mRNA expression
levels are decreased, consistent with Notch activation,
decreasing p63 expression in progenitor cells in vivo.
Requirement of DNp63 downmodulation and activation
of Notch signaling in vivo. To address whether down-
modulation of DNp63 is required to establish luminal cells
in vivo, we resorted to mammary gland reconstitution experi-
ments. Briefly, in 3-week-old mice, the inguinal mammary
glands can be cleared of endogenous epithelium by
surgically removing the nipple-near half that contains the
rudimentary ductal system. The MMECs that are injected into
the remaining ‘cleared’ fat pad will give rise to a new ductal
system.34 Primary MMECs infected with either GFP-DNp63
or a GFP control virus, were injected into contra lateral-
cleared mammary fat pads. After 3 months, MMECs infected
with GFP virus gave rise to ductal systems with widespread
GFP expression (Figure 6a, b, and d), whereas GFP-DNp63
virus-infected MMECs reconstituted less overall (Figure 6a)
and had spotty GFP expression (Figure 6c and e). To
determine the specific cell fate of the infected cells, we
performed immunohistochemistry for the myoepithelial cell
marker, smooth muscle actin (SMA). Coimmunostaining
revealed that GFP control MMECs were present in both
cell compartments with 66% being SMA() and being 34%
SMA(þ ) (Figure 6f and g). Among the DNp63-GFP-infected
cells, only 14% were SMA() but 86% were SMA(þ ) (Figure
6h and i). Thus, constitutive DNp63 expression impairs
overall reconstitution and specifically inhibits luminal cell
fate, indicating that downmodulation of DNp63 is required to
establish and/or maintain luminal cell lineage in vivo.
To address whether Notch activation is functionally
important for the control of DNp63 expression in vivo, we
deleted both alleles of the central Notch mediator CBF1/RBP-
Jk in the mammary epithelium. Mice in which both alleles of
RBP-Jk were flanked by loxP sites (Rbpsuhfl/fl) were crossed
with MMTV-Cre transgenic mice.30 Analysis of mammary
glands from 5-week-old mice by whole mount microscopy
revealed no obvious difference (Figure 7a and b), which is
consistent with previous work.30 However, as the MMTV-LTR
is only active in a subset of MMECs, it was conceivable that
CBF1/RBP-Jk-deficient MMECs were outgrown by unde-
leted, wild-type (WT) MMECs. To address this concern, we
crossed the mice with a Cre reporter strain designated Z/EG
(LacZ/EGFP),35 in which Cre excision activates expression
of EGFP. Mammary epithelium of MMTV-Cre.Z/EG double
transgenic mice, with one WT allele of RBP-Jk, showed a
strong GFP signal (Figure 7d and f). Immunostaining revealed
that about 20% of the MMECs express GFP (Figure 7h and l).
In contrast, in MMTV-Cre.Z/EG double transgenic mice
homozygous for the conditional RBP-Jk allele, GFP signal
was scarce (Figure 7c and e) and few GFP-expressing cells
were detected by immunostaining (Figure 7g and k), indicating
that RBP-Jk-deficient cells were negatively selected. Inter-
estingly, coimmunostaining for GFP and p63 revealed that in
RBPfl/WT double transgenic epithelia, GFP(þ ) cells were
present in both p63(þ ) and p63() compartments (Figure 7h,
j and l), whereas in RBPfl/fl double transgenic epithelia
all the GFP(þ )/RBP-Jk-deficient MECs expressed p63
(Figure 7g, i and k) and SMA (Supplementary Figure 4). This
indicates that RBP-Jk-deficient cells were unable to down-
modulate p63 expression and did not contribute to the luminal
layer. Thus, both activation of canonical Notch signaling and
downmodulation of DNp63 are required to establish and/or
maintain luminal cells in vivo.
Discussion
In the present paper, we provide, to our knowledge, the
first evidence for a role of DNp63 in controlling cell fate in
the breast epithelium, both in primary HBECs in vitro and in
the mouse mammary gland in vivo. We show that DNp63 is a
determinant of basal/myoepithelial cell type under negative
Notch control. Our results regarding the Notch function in this
context are in line with studies that implicated Notch signaling
in restricting bipotential progenitors to a luminal cell fate.10,12
They extend them by providing evidence for a functional
requirement of canonical Notch signaling in establishing the
luminal cell lineage in vivo and identifying suppression of
DNp63 expression as an important underlying mechanism.
Our findings are consistent with a model for the establish-
ment of breast epithelial cell fates through antagonistic
Figure 3 Activation of Notch signaling in HBECs. (a) QRT-PCR analysis of DNp63 mRNA levels normalized to TBP in HBECs from eight different donors infected with
control (filled bar) or NICD (open bar)-expressing retrovirus. (b) Immunoblot of p63 protein in HBEC lysates from three different donors infected with control (C) or NICD (N)
retrovirus. (c) Crystal violet staining of HBECs from four different donors 20–26 days after infection with control (C) or NICD-expressing virus, top: high NICD (Hi) expression by
retrovirus, bottom: low NICD expression by lentivirus (Lo). (d) Growth curves of HBECs from three different donors infected with control (squares) or NICD-expressing (circles)
lentivirus. (e) Percentage of BrdU-positive cells in control (filled bars) (40.7 and 27.1%) and NICD-expressing (open bars) (23.8 and 19.4%) HBECs on days 6 (patient S) and
11 (patient AE) after infection. (f) Percentage of Ki67-positive cells in control (filled bars) (58.8 and 83.9%) and NICD-expressing (open bars) (32.7 and 69.6%) HBECs on days
6 (patient P) and 8 (patient AK) after lentiviral infection. (g) QRT-PCR analysis of ITGB1, ITGB4, and ITGA6 mRNA levels normalized to TBP in HBECs from eight different
donors infected with control (filled bar) or NICD (open bar)-expressing retrovirus (P-values: ITGB1o 7.4 105; ITGB4o 2.5 107; ITGA6o 2.5 107). (h) ITGB1
and ITGB4 protein expression in HBECs from three different donors infected with control (C) or NICD-expressing retrovirus. (i) QRT-PCR analysis of CK18 mRNA expression
in HBECs infected with inducible NICD virus. At 7 days after infection, cells were treated with ethanol (black bars) or 4-OH-tamoxifen (open bars) for 8 h and analyzed either
directly after treatment (day 0) or 14 days later
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interaction of DNp63 and Notch (Figure 8). The striking global
changes observed with cultured HBECs suggest that myoe-
pithelial and luminal cells are interconvertible, controlled by
the relative balance of DNp63 and Notch expression and
activity (Figure 8, dashed arrows). Alternatively, they may
reflect increased plasticity of HBECs in vitro36 with a large
population of DNp63(þ ) progenitor-like cells37 that would be
the prime target for DNp63/Notch interplay leading to
Figure 4 DNp63 partially inhibits NICD effect in HBECs. (a) Crystal violet staining of HBECs double infected with two control viruses, control and NICD, or withDNp63 and
NICD viruses. (b) Photomicrographs of HBECs from three different donors double infected in this way. Note, that cell densities reduced and cells formed clusters in NICD-
expressing populations (middle panels). DNp63 and NICD coexpressing cell populations (right panels) show similar density to control (left panels) and cluster less than NICD-
only-infected cells. Scale bar: 0.05 mm. (c) QRT-PCR analysis of relative mRNA expression of ITGB1, ITGB4, and ITGA6 after infection with two control (open bars), control
and NICD (black bars), and DNp63 and NICD (gray bars) retroviruses. Three replicate samples were analyzed and normalized to TBP. Values represent the mean±S.D. of
three independent experiments with HBECs from distinct donors. Note, DNp63 expression partially overcomes NICD-induced reduction of integrin mRNA expression
(P-values: ITGB1, 0.02; ITGB4, 0.16; and ITGA6, 0.29). (d) ITGB4 protein levels in HBECs from different patients 9 days after infection with two control (open square), control
and NICD (black square) and DNp63 and NICD (gray square) retroviruses
DNp63/Notch antagonism controls breast cell fates
O¨ Yalcin-Ozuysal et al
1606
Cell Death and Differentiation
Figure 5 Notch signaling is activated during ductal outgrowth and reduces p63 expression levels in vivo. (a) Mammary glands of TNR mice (n¼ 4–6 per age value)
analyzed at different developmental stages were scored for overall GFP signal intensity as negative, weak, or positive. The percentage of each category was plotted over the
age of the mice. Strong activation of Notch signaling was specifically observed between 4 and 6 weeks of age. (b) Stereomicrograph of a whole-mounted mammary gland from
a 5-week-old TNR female. Black box represents the growing end of the mammary gland with TEBs indicated by arrows. Scale bar: 1 mm. (c) Fluorescence image of the area
indicated by gray box in b. Note that GFP expression reflecting Notch activity is detected at the growing front of the ductal system marked by red box, which corresponds to the
black box in b. (d) Higher magnification of TEBs (arrows) shown in c. Scale bar: 100mm (e) Coimmunofluorescence for GFP (red) and p63 (green) on a mammary gland
section from a 6-week-old TNR transgenic female; TEB (left panel) and subtending ducts (right panel). Note, Notch activity detected by GFP expression (red), is found
exclusively in the body cells of TEB and luminal cells of immediately subtending duct; it is mutually exclusive with p63 expression. Scale bar: 30 mm. (f) Representative FACS
dot plot showing the distribution of TNR MECs based on CD24 and GFP expression. Boxes outline the sorted populations. (g) Representative QRT-PCR analysis of the four
distinct FACS-sorted MMEC populations. Three replicate samples were analyzed and normalized to 36B4. Note, p63 expression is specific to the CD24lo population. Within
the CD24lo population, p63 expression is lower in the GFP(þ ) than in GPF() subpopulations (P-values of four independent experiments is 0.07)
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differentiation along specific lineage (Figure 8, full arrows). In
either scenario, activation of Notch signaling triggers a
transition to luminal progenitors by downmodulating DNp63
expression and associated decrease of basal markers.
Increase in Notch signaling activity in luminal progenitor stage
I cells results in luminal progenitor stage II cells with a CD24hi
phenotype and complete loss of DNp63 expression. As
luminal progenitor stage II cells differentiate into mature
luminal cells, Notch signaling is, however, reduced, as
suggested by our analysis of the TNR reporter mouse with
loss of GFP signal in the cells of the mature ducts. This
interpretation is in line with the model of transient Notch
activation driving luminal cell fate proposed by Raouf et al.10
Thus, in accordance with the proposed hierarchical transition
from bipotential progenitors, with concomitant reduction to
either luminal or myoepithelial progenitor cells,9 our data
reveal that activation of Notch signaling in bipotential
progenitors with concomitant reduction in p63 expression
and activity (Figure 8, full arrow) can specify a luminal
progenitor cell fate characterized by decreased DNp63,
ITGA6, and ITGB1 expression, whereas the persistent
DNp63 expression and attendant low Notch activity is required
to maintain the multi-potential progenitor state and/or to favor
myoepithelial differentiation.
In a broader context, we note that during pubertal ductal
elongation, proliferation and cell fate determination occur
specifically at the growing tips of the ducts, whereas at other
stages, in particular pregnancy, proliferation is spread all over
the ductal system. Previous studies of the RBPfl/fl.MMTV-Cre
mouse model showed that mammary glands looked normal
until mid-pregnancy, suggesting that Notch function is not
important in puberty.30 However, our finding that Notch
Figure 6 Constitutive DNp63 expression is incompatible with luminal cell fate. (a) Mammary gland reconstitution with MMECs infected with GFP only (control) or GFP-
DNp63 (DNp63)-expressing viruses. Each circle represents one mammary gland; the blackened region represents the area filled with outgrowth (b–e). Fluorescence images
show outgrowths of mammary glands reconstituted with control (b and d) orDNp63-expressing MMECs (c and e). Arrows show spotty GFP pattern in GFP-DNp63-expressing
outgrowths. Scale bars: (b, c) 0.5 mm; (d, e) 50mm. (f–i) Double immunofluorescence for SMA (f and h, left panels) and GFP (f and h, middle panels). GFP control-infected
MMECs are present both in SMA(þ ) and SMA() compartments (f right panel, g), whereas the rare GFP-DNp63-infected MMECs that contribute to outgrowth are SMA(þ )
(arrows in h and i), scale bar: 100mm
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signaling activity in vivo is specifically increased during
pubertal ductal morphogenesis points to the possible
importance of this pathway also at this stage, while it could
still be active at lower levels at other stages. In fact, using the
same mouse model as those in the previous studies, but
adding a GFP reporter to visualize RBP-jk deletion, we found
that in the apparently normal mammary glands before preg-
nancy, cells with intact Notch signaling had been selected.
Few RBP-jk-deficient cells, which are GFP positive, were
found and these were limited to the basal compartment. This
suggests that the appearance of an overt phenotype in RBPfl/
fl.MMTV-Cre females only during pregnancy30 is more likely a
consequence of the increased and more widespread expres-
sion of Cre under MMTV control at this time than an essential
function of Notch/RBP-jk limited to pregnancy. Consistent
with this conclusion is the finding that expression of a
dominant-negative Xenopus suppressor of hairless (RBP-jk
homolog) gene impaired both pubertal ductal outgrowth and
alveologenesis during pregnancy.38
The parallels of our findings in HBECs from multiple donors
and in mouse point to a central and conserved antagonistic
role of Notch and DNp63 in breast epithelial homeostasis.
With Notch signaling implicated in breast carcinogenesis,15–16
the question arises whether deregulation of this antagonism
has a role in tumorigenesis. The Notch pathway has been
targeted and g-secretase inhibitors are currently in clinical
trials. Will they affect cell type specification in tumors and/or
the normal breast epithelium in treated patients?
Materials and Methods
Primary cell culture and viral infection. Normal human breast tissue
was obtained from women undergoing reduction mammoplasties, with no previous
history of breast cancer, who gave informed consent. All samples were confirmed by
histopathological examination to be free of malignancy. Primary HBECs prepared
from these specimens were infected at passage 1 or 2 with high-titer amphotropic
retro- or lentiviruses as described.39 For selection, neomycin (400mg/ml) or
puromycin (2 mg/ml) were applied. For growth analysis, at each passage infected
HBECs were plated at equal numbers, stained with 0.5% Crystal violet (Sigma,
St. Louis, MO, USA) or counted in parallel, and population doublings were
determined and used to calculate total cell numbers. For immunofluoresence,
HBECs were cultured in Lab-Tek II-CO2 chamber slide system (NUNC, Thermo
Fisher Scientific, Langenselbold, Germany). Proliferation was assessed by
immunostaining for Ki67 with anti-Ki67 (1 : 500; Neomarkers, Lab Vision Products
Thermo Fisher Scientific, Fremont, CA, USA) or BrdU incorporation with anti-BrdU
(1 : 300; Oxford Biotechnology, Oxford, UK) after 4 h of incubation with 50 mM BrdU.
To activate Notch signaling shortly, HBECs were infected with inducible NICD-ER
virus and grown on selection medium containing neomycin. HBECs were treated 7
days after infection with 1 mM 4-OH-tamoxifen (Sigma) or ethanol as control for 8 h.
Cell separation. Single cell suspensions of HBECs were prepared as
described39 and labeled with anti-CD10/RPE antibody (10ml for 1 106 cells;
DAKO, Glostrup, Denmark; clone SS2/36) for 30 min at room temperature. Labeled
HBECs were washed with PBS, 2% bovine serum albumin, incubated with anti-PE
micro beads (10 ml/106 cells; Miltenyi Biotec, Bergisch Gladbach, Germany) for
30 min at room temperature and separated by MACS columns placed in a
MiniMACS Separator (Miltenyi Biotec) according to manufacturer’s protocol.
Figure 7 Canonical Notch signaling is required for luminal cell fate. (a, b) Whole
mount stereomicrographs of mammary glands from 5-week-old littermates, either
MMTV-cre.Rbpfl/fl (a) or MMTV-cre.Rbpfl/wt (b). Scale bar: 2 mm. (c–f) Fluorescent
stereomicrographs of mammary glands from 4-week-old MMTV-cre.Z/EG
transgenic mice on Rbpfl/fl (c, e) or Rbpfl/wt background (d, f). Scale bar: (c, d)
0.5 mm; (e, f) 100mm. GFP (g and h) and p63 (i and j) immunofluorescence
on histological sections of mammary glands from MMTV-cre.Z/EG double
transgenic mice, either Rbpfl/fl (g, i, k) or Rbpfl/wt (h, j, l). Note that in Rbpfl/wt
double transgenic mice, GFP(þ ) cells are in both p63-positive and -negative
compartments (l), whereas in the Rbpfl/fl double transgenic epithelium, they are
only in the p63-positive compartment (k). Scale bar: 100mm
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FACS. Mouse mammary epithelial cells were prepared as described2,8 without
pre-plating. Dead cells were excluded by 7-amino-actinomycin-D staining (1 : 1000;
Invitrogen, Paisley, UK). Cocktail of biotin-labeled anti-CD31 (clone MEC 13.3;
1 :5 00; BD Biosciences, Erembodegem, Belgium), anti-CD140a (clone APA5;
1 : 500; eBiosciences, Hatfield, UK), anti-TER119 and anti-CD45 (1 : 50 and
1 : 1000, respectively; gift from Anne Wilson, Ludwig Institute, Lausanne,
Switzerland), streptavidin-APC (0.06mg for 1 106 cells, eBiosciences), and PE-
conjugated anti-mouse CD24 (clone M1/69; 0.5mg/ml; BD Biosciences) were used
for stromal and epithelial cells. BD FACSAria (I) Cell Sorting System (BD
Biosciences) was used for sorting.
Mammary gland reconstitution assay. Mouse mammary epithelial cells
were isolated from 2-month-old mice, spin infected with high-titer lentivirus on day 2
in culture as described,40 and 50 000 control and DNp63-infected MMECs were
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Figure 8 DNp63/Notch antagonism in the regulation of breast epithelial cell fate. The putative stem cell gives rise to a bipotential progenitor cell that can take a
myoepithelial or luminal cell fate. Notch activation in the bipotential progenitor cell specifies differentiation along the luminal cell lineage. As a result, a CD24lo cell with
decreased p63 expression forms and the luminal progenitor stage I cell is determined. Continued and incremental Notch activation results in a luminal progenitor stage II cell,
characterized by a CD24hi phenotype and lack of DNp63. This cell in turn gives rise to various differentiated luminal cells that have no detectable Notch activity. Transition of
myoepithelial cells into luminal cells may occur directly or through a progenitor stage (dotted arrows)
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injected into contra lateral fat pads of 3-week-old mice divested of endogenous
epithelium. Engrafted glands were analyzed 3 months later.
Viral constructs. High NICD expression levels were obtained with MSCV-
NICD retrovirus using CMV (cytomegalovirus) promoter.39 For low-level expression,
NICD cDNA was subcloned into psd64, lentiviral vector that uses human PGK
promoter using Gateway LR Clonase II Enzyme Mix (Invitrogen).
Protein preparation and immunoblotting. Cells were lysed in RIPA
buffer and sonicated. Total protein (20–40mg) was subjected to SDS/PAGE
followed by immunoblotting with anti-p63 (clone 4A4; 1 : 200; Neomarkers), anti-
CK14 (1 : 1000; Neomarkers), anti-CK18 (clone Ab1, DC10; 1 : 2000; Neomarkers),
anti-g-tubulin, (1 : 10000; Sigma), anti-ITGA6 (1 : 200; Abcam, Cambridge, UK) anti-
ITGB1 (clone 18; 1 : 2500; BD Biosciences), and anti-ITGB4 (clone 7; 1 : 250; BD
Biosciences).
RNA isolation and qRT-PCR. Total RNA obtained from HBECs was
isolated using RNeasy (Qiagen AG, Hombrechtikon, Switzerland), cDNA was
synthesized using random p(dN)6 primers (Roche Diagnostics AG, Rotkreuz,
Switzerland) and MMLV reverse transcriptase (Invitrogen). Semi-quantitative
real-time RT-PCRs (QRT-PCR) was performed with SYBR Green PCR Core
Reagents System (Qiagen) on an iCycler real-time PCR detection system
(Bio-Rad Laboratories AG, Reinach, Switzerland). Primers: DNp63, Hes610,
Hey227, TAp63 50-GTCCCAGAGCACACAGACAA-30, 50-TGCGGATACAGTCCAT
GCTA-30, total p63 50-AGCAGCAAGTTTCGGACAGT-30, 50-TGCTGTTGCCTGT
ACGTTTC-30, CK14 50-CACAGCCACAGTGGACAATG-30, 50-GGCTCTCAATCT
GCATCTCC-30, CK18 50-CACAGTCTGCTGAGGTTGGA-30, 50-GAGCTGCTCCAT
CTGTAGGG-30, CD24 50-CTGCTGGCACTGCTCCTAC-30, 50-ACCACGAAGAGA
CTGGCTGT-30, ITGA6 50-GGCGAGCAAGCTATGAAATC-30, 50-AAAGCAACCAT
TTCCCATTG-30, ITGB1 50-GGTCCAACCTGATCCTGTGT-30, 50-AGCAGTAATGC
AAGGCCAAT-30, ITGB4 50-ACTGACCCGCTCAGAACACT-30, 50-CTCCTGCCAG
CTCACTCTG-30, NOTCH1 50-CTGAAGAACGGGGCTAACAA-30, 50-CAGGTTGTA
CTCGTCCAGCA-30, Hey1 50-GGGAGGGGAACTATATTGAATTTT-30, 50-ATTTGT
GAATTTGAGATCCGTGT-30, TBP 50-TAGAAGGCCTTGTGCTCACC-30, 50-TCTG
CTCTGACTTTAGCACCTG-30.
Total RNA from equal numbers of MMECs was isolated with PicoPure RNA
isolation kit (Arcturus, Mountain View, CA, USA). Amplified cDNA was prepared with
WT-Ovation RNA Amplification System (NuGEN, Bemmel, The Netherlands).
Primers: GFP 50-GCACGACTTCTTCAAGTCCGCCATGCC-30, 50-GCGGATCTTG
AAGTTCACCTTGATGCC-30, p63 50-CCTTATGAGCCACCACAGGT-30, 50-GCT
GTCTTCATCTGCCTTCC-30, 36B4 50-GTGTGTCTGCAGATCGGGTA-30, 50-CAG
ATGGATCAGCCAGGAAG-30, ITGA6 50-CCCGTCTCCCTTGTCACTAA-30, 50-CA
ACAGCAAGATGGCTTGAA-30, ITGB1 50-TGCTGCTTGCAGGACTACAG-30, 50-TC
GAGACAGAGCAAGCATGT-30. For all results, two-tailed, paired Student’s t-test was
used to calculate statistical significance.
Mice. Transgenic Notch reporter mice31 were genotyped using GFP-specific
primers 50-TCCTTGAAGAAGATGGTGCG-30, 50-AAGTTCATCTGCACCACCG-30;
MMTV-Cre, Rbpsuhfl/fl, and Z/EG mice, as described.30,35 All mice were maintained
and handled according to the Swiss guidelines for animal safety.
Mammary gland whole mount. Glands were processed as described.40
GFP images were acquired on Leica MZ16F stereoscope with Leica DC300F
camera, whole mount images were taken on a Leica MZFLIII stereoscope (Leica,
Wetzlar, Germany) with Pixelink PL-A622 camera (Pixelink, Ottawa, Canada).
Immunostaining. Mammary glands were fixed with 4% paraformaldehyde and
paraffin embedded. Sections (mm) were stained with the following antibodies: anti-
GFP (1 : 100; Molecular Probes, Invitrogen), anti-p63 (clone 4A41:100; Molecular
Probes, Invitrogen), anti-SMA (clone Ab1; 1 : 200; Neomarkers); mouse-on-mouse
immunodetection kit (Vector Laboratories, Burlingame, CA, USA) was used to block
unspecific staining of mouse antibodies. Images were acquired on Leica DM2000
microscope with a Pixelink PL-A622C camera and Zeiss Axioplan 2-imaging
fluorescence microscope (Go¨ttingen, Germany) with Axiocam Mrm.
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